Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.48%11.13B | -1.29%5.73B | -8.91%10.65B | -13.39%5.81B | 0.57%11.69B | -1.41%6.71B | 1.42%11.63B | 9.21%6.8B | 21.27%11.46B | 39.76%6.23B |
| Operating income | 4.48%11.13B | -1.29%5.73B | -8.91%10.65B | -13.39%5.81B | 0.57%11.69B | -1.41%6.71B | 1.42%11.63B | 9.21%6.8B | 21.27%11.46B | 39.76%6.23B |
| Cost of sales | -6.36%-7.09B | 1.97%-3.72B | 11.47%-6.66B | 17.03%-3.79B | -5.16%-7.53B | -1.63%-4.57B | -2.95%-7.16B | -14.61%-4.5B | -41.10%-6.95B | -76.33%-3.93B |
| Operating expenses | -6.36%-7.09B | 1.97%-3.72B | 11.47%-6.66B | 17.03%-3.79B | -5.16%-7.53B | -1.63%-4.57B | -2.95%-7.16B | -14.61%-4.5B | -41.10%-6.95B | -76.33%-3.93B |
| Gross profit | 1.35%4.04B | -0.01%2.01B | -4.27%3.99B | -5.59%2.01B | -6.78%4.17B | -7.34%2.13B | -0.94%4.47B | 0.00%2.3B | -0.31%4.51B | 3.26%2.3B |
| Impairment and provision | ---- | ---- | ---- | ---- | ---1.2B | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---1.2B | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 50.27%-239.2M | 67.31%-106.42M | ---481.03M | ---325.5M |
| Special items of operating profit | -0.55%-3.12B | 4.40%-1.54B | 9.52%-3.1B | 7.51%-1.61B | 1.26%-3.43B | 3.67%-1.74B | 5.59%-3.47B | 4.47%-1.8B | 5.95%-3.68B | -1.30%-1.89B |
| Operating profit | 4.13%926.27M | 17.23%479.09M | 293.92%889.49M | 2.78%408.67M | -160.23%-458.69M | 0.85%397.6M | 113.45%761.55M | 334.12%394.23M | -42.39%356.77M | -75.31%90.81M |
| Financing cost | 17.41%-710.44M | 8.66%-366.02M | -22.49%-860.24M | -23.51%-400.71M | ---702.3M | ---324.45M | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | -117.81%-742K | 518.28%3.11M | --4.17M | ---744K | ---- | ---- |
| Share of profit from joint venture company | ---- | ---- | 99.82%-128K | 99.75%-165K | -30.09%-69.59M | -641.64%-65.22M | -69.79%-53.5M | -3,133.09%-8.79M | -12,919.83%-31.51M | 82.66%-272K |
| Earning before tax | 641.06%215.83M | 1,351.80%113.07M | 102.37%29.13M | -29.47%7.79M | -272.89%-1.23B | -97.13%11.04M | 118.96%712.22M | 324.89%384.69M | 253.16%325.27M | 13.24%90.54M |
| Tax | 52.41%-8.97M | 11.96%-5.51M | 47.76%-18.85M | -151.28%-6.25M | 77.30%-36.08M | 115.18%12.2M | -34.21%-158.9M | -91.44%-80.36M | -2,725.70%-118.39M | -181.30%-41.98M |
| After-tax profit from continuing operations | 1,912.88%206.86M | 6,911.73%107.56M | 100.81%10.28M | -93.40%1.53M | -329.05%-1.27B | -92.36%23.24M | 167.47%553.32M | 526.68%304.33M | 114.13%206.87M | -63.09%48.56M |
| Earning after tax | 1,912.88%206.86M | 6,911.73%107.56M | 100.81%10.28M | -93.40%1.53M | -329.05%-1.27B | -92.36%23.24M | 167.47%553.32M | 526.68%304.33M | 114.13%206.87M | -63.09%48.56M |
| Profit attributable to shareholders | 1,912.88%206.86M | 6,911.73%107.56M | 100.81%10.28M | -93.40%1.53M | -329.05%-1.27B | -92.36%23.24M | 167.47%553.32M | 526.68%304.33M | 112.89%206.87M | -63.28%48.56M |
| Basic earnings per share | 1,775.00%0.15 | 8,100.00%0.082 | 100.83%0.008 | -94.44%0.001 | -329.15%-0.967 | -92.24%0.018 | 167.09%0.422 | 527.03%0.232 | 113.51%0.158 | -63.37%0.037 |
| Diluted earnings per share | 1,900.00%0.14 | 7,200.00%0.073 | 100.72%0.007 | -93.75%0.001 | -358.56%-0.967 | -92.23%0.016 | 167.14%0.374 | 524.24%0.206 | 112.12%0.14 | -62.92%0.033 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PwC accounting firm | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.